-Soojung Shin Researcher Activity Profile

Research Author Detailed Information 

Soojung Shin Publication Rate By Year

Soojung Shin has published 1 paper(s) in 2006, 6 paper(s) in 2007, 5 paper(s) in 2008, for a total of 12 research publications in total.

Soojung S Shin Author Information

LAST NAME: shin

FIRST NAME: soojung

INITIALS: S

AFFILIATION:

Papers

Soojung Shin's Publication Record

1. A molecular scheme for improved characterization of human embryonic stem cell lines. Year Published: 2006
Stem Cell Center, American Type Culture Collection (ATCC), Manassas, VA, USA. rjosephson@globalstem.com
2. Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research. Year Published: 2007
GlobalStem, Inc., 6 Taft Court, Rockville, Maryland 20850, USA. rjosephson@globalstem.com
3. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Year Published: 2007
4. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Year Published: 2007
Division of Hematology, Department of Medicine, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, 98195, USA.
5. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Year Published: 2007
Division of Hematology, Department of Medicine, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, 98195, USA.
6. An SMA Project Report: Neural Cell-Based Assays Derived from Human Embryonic Stem Cells. Year Published: 2007
Regenerative Bioscience Center, University of Georgia, Athens, GA 20602.
7. Creation of engineered human embryonic stem cell lines using phiC31 integrase. Year Published: 2008
Invitrogen Corporation, Carlsbad, California 92008, USA. bhaskar.thyagarajan@invitrogen.com
8. An SMA project report: neural cell-based assays derived from human embryonic stem cells. Year Published: 2007
Regenerative Bioscience Center, University of Georgia, Athens, GA 20602, USA. pgwilson2@earthlink.net
9. Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. Year Published: 2008
10. Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. Year Published: 2008
Department of Human Physiology and Pharmacology, Vittorio Erspamer Faculty of Pharmacy, University of Rome La Sapienza, Rome, Italy.
11. Stem cells for the treatment of neurological disorders. Year Published: 2008
CRL, Invitrogen Corporation, 1600 Farady Avenue, Carlsbad, CA 92008, USA. mahendra.rao@invitrogen.com.
12. Creation of engineered human embryonic stem cell lines using phiC31 integrase. Year Published: 2008
Invitrogen Corporation, Carlsbad, California 92008, USA. bhaskar.thyagarajan@invitrogen.com